Verismo Therapeutics, a clinical-stage CAR T company developing a novel KIR-CAR platform technology, today announced the presentation of new preclinical data from its lead clinical pipeline, ...

Verismo Therapeutics, a clinical-stage CAR T company developing a novel KIR-CAR platform technology, today announced the presentation of new preclinical data from its lead clinical pipeline, ...

Britons have been warned that skipping routine dental appointments might be doing more harm than they realise, after an ...

Translational study shows that multiple immunological biomarkers predict the clinical activity of PDS0101 combination therapy PDS01ADC reprograms ...

Exploratory Phase 2 analysis shows Verrica’s novel oncolytic peptide, VP-315, reprograms the tumor microenvironment, increasing cytotoxic ...

From November 6 to 9, the 2025 Chinese Congress on Holistic Integrative Oncology (CCHIO) was held in Kunming, Yunnan. This conference was jointly ...

Stage 2 oral cavity cancer involves tumors larger than 2 cm but not exceeding 4 cm, without lymph node or distant spread. Diagnosis includes physical exams, biopsies, imaging tests, and endoscopy to ...

Medication burden, characterized by polypharmacy and suboptimal treatment adherence, is a predictor for acute care use among ...

Researchers at the School of Dentistry at UT Health San Antonio, the academic health center of The University of Texas at San Antonio, have been awarded three multi-year grants totaling $6 million ...

Researchers believe inflammation in the gums could influence blood vessel health in the brain. A new study links gum disease ...

A woman says she’s been left terrified to ever visit the dentist again after a botched dental job left her in constant pain ...

Limited evidence from three small studies found no short-term serious health harms of oral nicotine pouches in people who smoke. We are uncertain if oral nicotine pouches help people quit smoking ...